Paediatric asthma trial

Phase III, A placebo controlled, randomised, three period cross-over trial to investigate the protective effect in a histamine challenge test of a new formulation compared to a reference formulation in paediatric patients aged 4 - 12 years with asthma. The population selected for this trial were paediatric subjects with proven asthma. 39 subjects were screened 33 patients were randomised to treatment and...